We serve Chemical Name:5-nitro-8-pyrrolidin-1-ylquinoline CAS:294194-84-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-nitro-8-pyrrolidin-1-ylquinoline
CAS.NO:294194-84-6
Synonyms:5-nitro-8-pyrrolidinylquinoline
Molecular Formula:C13H13N3O2
Molecular Weight:243.26100
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:452ºC at 760 mmHg
Density:N/A
Index of Refraction:1.676
PSA:61.95000
Exact Mass:243.10100
LogP:3.33140
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-nitro-8-pyrrolidinylquinoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-nitro-8-pyrrolidinylquinoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-nitro-8-pyrrolidinylquinoline Use and application,5-nitro-8-pyrrolidinylquinoline technical grade,usp/ep/jp grade.
Related News: For one, people who are surrounded by others of similar body size may not perceive their weight to be outside of the norm and therefore not seek out bariatric surgery,” said Sandon. “[And] there are differences in ethnicities and culture between states with the highest rates of obesity compared to states with lower rates. 5-nitro-8-pyrrolidin-1-ylquinoline manufacturer In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed. 5-nitro-8-pyrrolidin-1-ylquinoline supplier If the Justice Department concludes that an internal investigation was thorough, it can result in a non-prosecution agreement with few, if any, penalties, the experts said. However, a company-led investigation that appears to have been poorly handled could lead to harsher outcomes. 5-nitro-8-pyrrolidin-1-ylquinoline vendor Currently allowed as a second-line treatment, Sarclisa is expected to have top-line data from the phase 3 IMROZ trial later this year. The trial is adding Sarclisa to a VRd cocktail of Velcade, Revlimid and dexamethasone, which has established itself as the standard-of-care first-line therapy for patients with myeloma. 5-nitro-8-pyrrolidin-1-ylquinoline factory Both were in Siberia, and both are Chinese nationals who had recently traveled to China.
